Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Brow Lifting
NCT02942303Phase 4Unknown
- Sponsor
- Saint Joseph's University
- Start
- Oct 2016
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of botulinum toxin type A in Brow ptosis (2 arms), sponsored by Saint Joseph's University. Primary endpoint: Objective assessment of eyebrow shape at 15 days. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
Brow ptosis
Beyond the preview
Go deeper on NCT02942303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02942303.